Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

World News

King Charles cancels engagements after experiencing temporary side effects of cancer treatment

by admin March 28, 2025
March 28, 2025
King Charles cancels engagements after experiencing temporary side effects of cancer treatment

Britain’s King Charles “required a short period of observation in hospital” on Thursday after experiencing “temporary side effects” from a scheduled cancer treatment in the morning, Buckingham Palace has said.

“His Majesty has now returned to Clarence House and as a precautionary measure, acting on medical advice, tomorrow’s diary program will also be rescheduled,” the palace said in a statement.

“His Majesty would like to send his apologies to all those who may be inconvenienced or disappointed as a result,” it added.

The King was set to receive credentials from the ambassadors of three countries on Thursday, and was scheduled to undertake four public engagements in Birmingham, central England, on Friday.

Charles’ cancer diagnosis was first announced in February last year, after he underwent a “corrective procedure” for a benign enlarged prostate the month before.

He briefly stepped away from public-facing duties while he received treatment for the undisclosed form of cancer, returning to them a few months later in April 2024. In his first official engagement since his diagnosis, Charles visited a cancer treatment center, where he leaned on his own personal experience when talking to medical teams as well as while connecting with patients and their families.

Thousands of people sent the King messages of support when he was first diagnosed, which he said “reduced me to tears,” according to a statement released by Buckingham Palace at the time. “Such kind thoughts are the greatest comfort and encouragement,” Charles said.

This is a developing story and will be updated.

This post appeared first on cnn.com

previous post
India among top suppliers of illicit fentanyl precursors, US intelligence report says
next post
FCC is investigating Disney and ABC for DEI initiatives

Related Posts

Baltic states switch to European power grid, ending...

February 10, 2025

Rubio and Bukele to discuss sending suspected gang...

February 1, 2025

The UK, Germany and Canada have slashed foreign...

June 13, 2025

White South Africans gather in support of Trump...

February 16, 2025

Deported mom says toddler’s return to Venezuela after...

May 18, 2025

Israel carries out first strikes against Houthi targets...

July 7, 2025

Volcano eruption in Guatemala forces hundreds to evacuate

March 11, 2025

Bodies of three hostages – an IDF soldier...

June 23, 2025

Russia launches largest drone attack against Ukraine since...

May 19, 2025

Israel to cut Gaza electricity immediately, energy minister...

March 10, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved